LoLa Capital Partners

Funding rounds backed by LoLa Capital Partners.

Export CSV
Funding disclosed in full
$263M
Median round
$263M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
LifeMine Therapeutics

Develops fungal genome-derived therapeutics for organ transplant rejection

$263MSeries D+Series EBiotechUnited States
9 participantsARCH Venture PartnersBezos ExpeditionsGates FrontierGSKGV (Google Ventures)InvusLoLa Capital PartnersMilky Way InvestmentsRA Capital Management